Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by
Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pursuing an innovative portfolio of technologies to address a
Make a meaningful difference to patients around the world. Driven by a passion to help patients live healthier and more productive lives, our Field teams embrace Edwards Lifesciences values to build trusting, lasting relationships with medical
The Edwards Transcatheter Aortic Heart Valves unit (THV) consists of our SAPIEN family of transcatheter aortic and pulmonic heart valves which are the most widely prescribed transcatheter heart valves in the world! Edwards leadership in transcatheter